Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Cost of Revenue (2011 - 2026)

Updated

Vertex Pharmaceuticals' Cost of Revenue came in at $489.2 million for Q2 2026, up 20.0% from $407.5 million a year earlier and up 24.5% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Cost of Revenue (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vertex Pharmaceuticals reported Cost of Revenue of $1.76 billion, up 11.1% year-over-year; for FY2025, it came in at $1.65 billion, up 7.9% from FY2024.

  • Cost of Revenue has increased in each of the last 11 years, with a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $1.53 billion in FY2024 (+21.3%), $1.26 billion in FY2023 (+16.8%), $1.08 billion in FY2022 (+19.5%) and $904.2 million in FY2021 (+22.8%).
  • The Q2 2026 figure represents the highest quarterly Cost of Revenue in data going back to Q3 2011.
  • Year-over-year, Cost of Revenue has increased for 37 consecutive quarters, with growth averaging 12.2% over the last eight quarters.
  • The year-over-year growth in Cost of Revenue has ranged between 5.7% (Q3 2025) and 29.9% (Q4 2023) over the last five years.
  • Business Quant data shows VRTX's Cost of Revenue at $392.8 million (Q1 2026), $466 million (Q4 2025) and $414.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 8.05 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 4.29 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.52 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.58 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 4.09 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 489.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 489.20 Mn
Mar 31, 2026 392.80 Mn
Dec 31, 2025 466.00 Mn
Sep 30, 2025 414.80 Mn
Jun 30, 2025 407.50 Mn
Mar 31, 2025 363.00 Mn
Dec 31, 2024 423.40 Mn
Sep 30, 2024 392.60 Mn
Jun 30, 2024 371.90 Mn
Mar 31, 2024 342.60 Mn
Dec 31, 2023 368.00 Mn
Sep 30, 2023 318.70 Mn
Jun 30, 2023 308.60 Mn
Mar 31, 2023 266.90 Mn
Dec 31, 2022 283.30 Mn
Sep 30, 2022 289.40 Mn
Jun 30, 2022 261.80 Mn
Mar 31, 2022 245.80 Mn
Dec 31, 2021 247.40 Mn
Sep 30, 2021 236.50 Mn
API Access

Vertex Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEY